Cite
HARVARD Citation
Leiter, A. et al. (2021). Metabolic disease and adverse events from immune checkpoint inhibitors. European journal of endocrinology. 184 (6), pp. 857-865. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Leiter, A. et al. (2021). Metabolic disease and adverse events from immune checkpoint inhibitors. European journal of endocrinology. 184 (6), pp. 857-865. [Online].